Rexo2 | RNA exonuclease 2
Physiological systems
17 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Mortality/aging
13 No significant impact
7 Not tested
Data collections
Gene metrics:7Significant phenotypes
0Associated diseases
Expression examined in:46Adult tissues
21Embryo tissues
decreased neutrophil cell number | 2 supporting datasets | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 5.15x10-5 | ||
decreased fasting circulating glucose level | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 2.89x10-11 | ||
preweaning lethality, complete penetrance | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | homozygote | Early adult | N/A * | ||
increased lymphocyte cell number | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 5.41x10-5 | ||
increased circulating HDL cholesterol level | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 9.76x10-11 | ||
increased circulating serum albumin level | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 5.04x10-5 | ||
increased circulating cholesterol level | 1 supporting dataset | Rexo2tm1b(EUCOMM)Wtsi | heterozygote | Early adult | 8.61x10-5 |
| | | | | | | | | |
External links
No external links available for Rexo2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Rexo2tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Rexo2tm1b(EUCOMM)Wtsi | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Rexo2tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |